good luck to gilead and all our pharmaceutical companies, the world needs to fight this disease together ..
a few questions with regards to the recent reports re recent remdesivir results ..
how many of these people that received this were younger and potentially healthy (therefore more likely to recover even without treatment ..
how many of these people were treated with other treatments possibly even remestemcel-L
did gileads trials that were cancelled ( in China) have not so good results maybe ..
even gilead have indicated they need controlled double blinded trials before they know for sure ...
there is room for multiple methods to cure /treat this nasty disease
my money is on mesoblast and remestemcel-L
I believe our msc's are the way forward because of our safety profile and efficacy ...
in "short course " we will know ...
Gilead vs Mesoblast, page-51
-
- There are more pages in this discussion • 224 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |